Ending new HIV cases by 2030? Novel interventions from Bristol research
The eighth in our series of webinars focusing on innovation and impact in primary care research.
Date: 4 December 2024, 10.30-11.30am, via Zoom.
Contributors
- Jeremy Horwood, Professor of Social Science and Health, Centre for Academic Primary Care, Bristol Medical School, University of Bristol
- Fiona Fox, Research Fellow, Bristol Medical School, University of Bristol
- Temilola Adeniyi, NIHR Doctoral Fellow, Bristol Medical School, University of Bristol
- Tom May, Research Fellow, Bristol Medical School, University of Bristol
- Siobhán Allison, Senior Research Associate, School of Psychological Science, University of Bristol
- Joanna Kesten, Research Fellow, Bristol Medical School, University of Bristol
- Sarah Denford, Research Fellow, Bristol Medical School, University of Bristol
- China Harrison, Research Fellow, Bristol Medical School, University of Bristol
Download the PowerPoint slides: Ending new cases of HIV by 2030 - Novel interventions from Bristol research (PDF, 3,503kB)
Watch the recording:
Description
The Government has set a goal of zero new HIV cases in England by 2030. To achieve this goal there is a crucial need for better access to HIV prevention, testing and treatment.
This involves increasing access to Pre-exposure Prophylaxis (PrEP), a pill that reduces the risk of getting HIV.
This also requires improving access to HIV testing, as reducing the number of people living with undiagnosed HIV provides access to treatment which saves lives and reduces HIV to undetectable levels so the virus cannot be passed on.
The webinar showcases the research that is taking place in Bristol in a range of settings to help meet the government’s HIV elimination goal.
This includes:
- An evaluation of community outreach and STI testing clinics in GP practices as part of the Common Ambition Bristol programme addressing HIV inequities in partnership with African and Caribbean Heritage communities.
- A qualitative evaluation of Emergency Department Opt-Out Blood Borne Virus Testing to outline good practice in implementing opt-out testing.
- The development of the Prevention and Testing for HIV in General Practice’ (PATH-GP) intervention to increase HIV testing and support access to treatment or PrEP.
- Literature review and qualitative findings examining the barriers and facilitators of community pharmacy PrEP delivery for pharmacists and community members and development of a pharmacy pilot.
.png)